(TERMINATED)PROT# CV185068: APPRAISE-2 Apixaban for Prevention of Acute Ischemic Safety Events-2 A Phase 3 Randomized Evaluation of the Safety and Efficacy of Apixaban in Patients with a Recent Acute Coronary Syndrome: Pharmacogenetics Blood Sample

Project: Research project

Project Details

StatusFinished
Effective start/end date9/18/09 → 9/17/12

Funding

  • PPD Development (CV185068 // CV185068)
  • Bristol-Myers Squibb Company (CV185068 // CV185068)